Stockreport

Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2019

GENMAB A/S  (GMXAY) 
NASDAQ:AMEX Investor Relations: ir.genmab.com
PDF Company Announcement Net sales of DARZALEX in the first quarter of 2019 totaled USD 629 millionGenmab will receive royalties on worldwide sales from Janssen Biotech, In [Read more]